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Engineering next-generation bioinks with
nanoparticles: moving from reinforcement
fillers to multifunctional nanoelements
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The application of additive manufacturing in the biomedical field has become a hot topic in the last
decade owing to its potential to provide personalized solutions for patients. Different bioinks have been
designed trying to obtain a unique concoction that addresses all the needs for tissue engineering and
drug delivery purposes, among others. Despite the remarkable progress made, the development of
suitable bioinks which combine printability, cytocompatibility, and biofunctionality is still a challenge. In
this sense, the well-established synthetic and functionalization routes to prepare nanoparticles with
different functionalities make them excellent candidates to be combined with polymeric systems in
order to generate suitable multi-functional bioinks. In this review, we briefly discuss the most recent
advances in the design of functional nanocomposite hydrogels considering their already evaluated or
potential use as bioinks. The scientific development over the last few years is reviewed, focusing the
discussion on the wide range of functionalities that can be incorporated into 3D bioprinted constructs
through the addition of multifunctional nanoparticles in order to increase their regenerative potential in
the field of tissue engineering.
1. Nanoparticles in nanocomposite
bioinks: simple fillers or something
more?
In recent years, 3D bioprinting has received an impressive
amount of attention in the areas of tissue engineering (TE)
and regenerative medicine, due to its potential for developing
functional tissues and organs surrogates that faithfully mimic
their native counterparts with high reproducibility.1,2 Although
other biofabrication strategies such as electrospinning3 or
freeze-drying4 have also been evaluated for this purpose, 3D
bioprinting allows a greater control over the properties of the
obtained constructs and a significantly improved versatility and
reproducibility. The main current limitation of 3D bioprinting
is the design of the suitable bioinks, that is, the biomaterials
that combined with cells and other elements, can be precisely
distributed hierarchically and spatially according to the desired
shape.5,6 In many cases, the cytocompatible printing conditions
for cells (bioprinting window) are not the same that allow high-
resolution degrees on the designed composites, hindering the
preparation of personalized constructs.7
The most common bioinks for TE purposes are based on
hydrogels. These are characterized by water-rich networks similar
to those observed in native tissues, as well as by high biocompat-
ibility and tunable mechanical performance.8–11 However, the high
polymer concentration and crosslinking density required to obtain
printable hydrogels limit the spreading, migration and/or
differentiation of the encapsulated cells. Moreover, using single
hydrogel-based bioink formulations it’s hardly enough to
design 3D bioprinted scaffolds that properly mimic the specific
structure and properties of most tissues. In this sense, printable
hydrogels can be modified with nanoparticles (NPs) and/or
biological factors, among others, for the biofabrication of 3D
constructs that seek to replicate the main characteristics and
properties of native tissues.12–15
In pioneering works that have used such strategy, the
addition of nanofillers was shown to allow tuning the physical
characteristics of the bioinks, such as viscosity, stiffness, and
nonlinear viscoelasticity (shear-thinning behavior), in order to
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improve their printability.16,17 In general, the mechanical properties
of hydrogels proportionally improve with nanofillers concentration,
but the incorporation of these nanostructures can, on the other
hand, have either positive or negative affects over the printing
fidelity of the constructs, depending on the type of filler and its
concentration.17 High concentrations of inorganic NPs strongly
increase the bioink viscosity, requiring higher printing pressures,
which, at the same time, decrease cell viability. Thus, to remain
within the biofabrication window,18 the bioinks with inorganic NPs
typically compromise printing fidelity to maintain high cell viability.
For instance, synthetic nanosilicateclays19 or silica NPs20 were
established as efficient nanofillers to provide bioinks with
easier printability and promote the adhesion and proliferation
of the cells encapsulated in the 3D bioprinted constructs.
The most recent advances in the design of complex bioinks
have shown that the fillers added to printable systems do not
only actuate as reinforcement elements but can also provide the
inks with essential biofunctionalities that can be exploited
in the field of TE of specific tissues. In fact, each tissue of
the human body is characterized by unique physicochemical
characteristics that regulate cell fate and confers its specific
properties.21 For instance, tendon or skeletal muscle tissues are
characterized by highly-anisotropic uniaxial aligned topography
that confers cells elongated morphologies,22,23 while bone
tissue presents high stiffness as one of their most remarkable
characteristics.24 In this way, the use of different nanofillers
such as stimuli-responsive NPs, ceramic NPs, or nanomaterials
incorporating biological factors, has been proposed to add
functionality to the bioinks in order to mimic the requirements
of specific tissues and complex cells microenvironments in the
designed 3D-bioprinted composites.25–27 Overall, the incorporation
of nanofillers in hydrogel-based bioinks has not only been evaluated
to improve the combination of printability and cytocompatibility of
the 3D bioprinted composites but also to provide them with the
functional properties required to control cells fate and reproduce
the physicochemical microenvironment of different native tissues.
In this review, we briefly discuss the main strategies based
on the addition of nanofillers to provide hydrogel-based bio-
materials with different functionalities that improve their
bioactivity and regenerative potential, targeting their use of in
3D bioprinting technology. In this way, the most recent works
that explored the incorporation of stimuli-responsive NPs to
design 3D bioprinted constructs with anisotropic magnetic or
electric properties are reviewed, as well as those which evaluated
the mineralization effect derived from the addition of inorganic
particles. The modification of bioinks using nanomaterials
decorated with biological factors that induce biochemical
signals to control cell fate and the incorporation of NPs for
real-time monitoring are also discussed (Fig. 1). In each of these
approaches, the essential characteristics/properties that the
incorporated nanofillers must meet to provide bioinks with
the desired functionality are commented while considering as
well the potential applications of the 3D bioprinted functional
nanocomposites in specific areas of TE and regenerative medicine.
2. Nanocomposite bioinks
Among different possibilities to enhance the performance of
hydrogel-based bioinks, the incorporation of micro-and nano-
fillers is one of the most efficient approaches to provide the 3D
bioprinted composites with the functional properties required
for TE purposes. By thoroughly understanding the precise
requirements of the target tissues/organs and the versatile
response of the incorporated organic and/or inorganic NPs,
the nanocomposite bioinks can be tuned to develop 3D-printed
scaffolds with the desired characteristics. In this sense, the
nanofillers not only passively improve the printability and
shape fidelity of the bioprinted constructs, but can also actively
contribute to meet the desired outcomes of the fabricated
scaffolds. This can include either to influence cell proliferation
or differentiation into the intended cell type, to maintain/
provide a cell niche by emulating the microenvironment of the
tissue/organ of interest, and/or to enable real-time monitoring
of the cellular processes during the maturation. Thus, for instance,
the addition of ceramic NPs has been positively tested to increase
the toughness and the stiffness of the scaffolds for bone TE,28 while
electrically-responsive NPs such as carbon nanotubes were used
to provide hydrogels with the electrical properties required to
engineer skeletal muscle, neural or cardiac tissues.29
In this section, we briefly reviewed the main strategies explored
to prepare nanocomposite bioinks for biomedical purposes,
classifying them into four groups according to the nature and
the characteristics of the incorporated nanomaterials: biological
factors-conjugated NPs, ceramic NPs, stimuli-responsive NPs,
and NPs for real-time monitoring (Fig. 2).
Fig. 1 Schematic illustration: preparation of 3D bioprinted constructs incorporating nanofillers with multiple functionalities.
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2.1. Bioinks with nanoparticles for controlled release of drugs
and bioactive molecules
Human organs are composed of multiple tissues organized into
complex architectures and gradients that cooperatively contribute to
their specific functionality. Tissue homeostasis and its regeneration
after injury are controlled by a finely orchestrated biological signal-
ing that involves different biophysical and biochemical cues. Our
capacity to develop successful regenerative strategies depends on
the ability to replicate the characteristic tissue spatiotemporal signal
transduction pathways, transcription factor instructions and protein
regulation.30
Different types of organic and inorganic NPs (e.g. liposomes,
dendrimers, polymeric micelles, nanogels, or silica nanomaterials)
have been extensively used as carrier vehicles for the controlled
delivery of bioactive molecules of interest for regenerative therapies,
including cytokines, chemokines, and growth factors,30 or for
the delivery of genetic material (e.g. plasmid DNA or siRNA).31–34
Nanocarriers can be engineered not only to protect their sensitive
cargo from harsh biomaterial processing conditions or from
deactivation within biological environments but also to enable
its programmed release triggered by specific stimuli.35 This set of
unique characteristics has made them a valuable tool as depots
of signaling molecules in the development of smart hydrogel
systems with spatial- and temporal-controlled release of chemical
cues for TE applications.33,36 Beyond the possibility of participating
in the crosslinked network to improve hydrogels mechanical
properties, the major advantage of incorporating drug-loaded
NPs into polymer networks is that the drug-loading process and
hydrogel preparation become relatively independent processes,
increasing, therefore, the engineering liberty to separately tune
the drug release kinetics and the hydrogel physicochemical
properties. As a representative example of such systems, meso-
porous silica NPs loaded with bone-forming peptide-1 were
incorporated into alginate-based hydrogels (RGD modified).37
This hybrid hydrogel resulted in an engineered time-responsive
osteogenic niche with the ability to sequentially trigger stem cell
adhesion, proliferation, and osteogenic differentiation. In a
different approach, hybrid hydrogels prepared by crosslinking
of pullulan-based nanogels encapsulating multiple GFs (human
bone morphogenetic protein 2 (BMP-2) and human fibroblast
growth factor 18 (FGF18)) with thiol-modified polyethylene
glycol, generated a biodegradable hydrogel that promoted effective
bone repair in critical-size skull bone defects.38
The potential of 3D bioprinting technology to fabricate
cellularized constructs with complex architectures, tailorable
mechanical properties, and spatially controlled biological function
would greatly benefit from adopting hybrid hydrogels incorporating
drug-releasing nanocarriers on their bioink development concepts.
Such strategies would significantly contribute to increasing the
biofunctionality of current hydrogel-based bioinks, allowing tomore
closely recreating the cascades of biological signaling that may
improve the regenerative outcomes of fabricated constructs. This
would be particularly relevant when targeting tissue interfaces that
show cellular and ECM gradients with different spatiotemporal
biological signaling requirements, such as osteochondral or
tendon-to-bone tissues.39 These and many other living tissues
Fig. 2 Classification of some representative nanofillers that can be incorporated within bioinks to provide them with different functionalities: release of
biological factors, enhancement of mineralization degree, stimuli-responsive capability and real-time monitoring properties.
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with spatial-dependent properties and cellular composition
could thus be simulated, for instance, by printing gradients or
interfacing different bioinks containing nanocarriers with the
relevant bioactive molecules of interest.
Interestingly, this strategy is making its way into the design
concepts of several 3D printed scaffolds engineered for the
regeneration of complex tissues.40,41 For instance, the sustained
and spatially controlled release of tenogenic (CTGF), chondrogenic
(TGF-b3 + CTGF), and osteogenic (BMP-2) growth factors from
microcarriers embedded in 3D printed scaffolds induced stem cell
differentiation gradients that better recreate the phenotypes
existing at tendon-to-bone interphases.42 A similar strategy was
adopted to fabricate disc scaffolds with micro-precise spatio-
temporal delivery of CTGF and TGF-b3, mimicking the native
multiphase fibrocartilage of temporomandibular joint (TMJ).41
However, so far, only a few bioink hydrogels incorporating
drug-release nano/microcarriers have been reported. For instance,
the sustained release of VEGF from gelatin microparticles was
used to create defined pro-vasculogenic differentiation regions in
3D bioprinted heterogeneous constructs that led to a significant
increase in its vascularization when applied in vivo (Fig. 3a).43
Similarly, the sustained release of TGF-b1 from nanospheres
embedded in constructs fabricated through stereolithography 3D
bioprinting with methacrylated gelatin (GelMA)/polyethylene
glycol diacrylate (PEGDA) based bioinks improved the chondrogenic
differentiation of encapsulated mesenchymal stem cells (MSCs)
(Fig. 3b).44 In a different recently proposed approach, gene-
activated bioinks were developed by the incorporation of amphi-
pathic peptide-plasmid DNA complexes for the non-viral transfer
of either osteogenic (BMP-2) or chondrogenic (combination of
TGF-b3, BMP-2, and SOX9) genes to encapsulated stem cells.45
Remarkably, this concept enabled spatially direct stem cell
differentiation in a bilayered construct for the recapitulation
of zonal phenotypes of the osteochondral unit, demonstrating
the potential of these gene-activated bioinks to engineer
spatially complex tissues.
Although still in its infancy, these examples serve to demonstrate
that the incorporation of drug-releasing nanocarriers into bioinks
can offer a valuable biomaterial design route to address the
need for increasing the biological functionality of current
bioinks. These strategies will certainly contribute to better
recapitulate the complexity of biological signaling existing in
Fig. 3 Bioinks with biological factors-conjugated nanoparticles: (a) quantification of vessel formation using Goldner’s trichrome staining in hEPCs
seeded scaffolds after one week of subcutaneous implantation in mice. The constructs with VEGF-loaded gelatin particles (slow VEGF release) presented
a higher vascularization than those in which free VEGF was directly incorporated (fast VEGF release) (scale bars = 50 mm). 3D bioprinted heterogeneous
scaffolds with two different regions were also prepared ( without VEGF, + VEGF-laden particles), observing no vessels formation in the control part of
the scaffolds and well-defied perfused vessels in the region with slow release of VEGF (reproduced with permission from ref. 43 copyright 2014 Elsevier).
(b) Fluorescence microscopy images of TGF-b1-embbedded nanospheres (in red) and human bone marrow MSCs (in green) incorporated in 3D printed
constructs. After three weeks of chondrogenic induction, the presence of TGF-b1-loaded NPs induced chondrogenic ECM secretions (the sections were
stained with safranin O and alcian blue to bind to cartilage proteoglycans and glycosaminoglycans, respectively) and high expressions levels of
chondrogenesis-related genes SOX-9, Collagen II and Aggrecan (reproduced with permission from ref. 44 copyright 2014 IOP Science).
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living tissues and consequently the potential of success of 3D
bioprinted constructs.
2.2. Enhancing mineralization using biofunctional inorganic
nanoparticles
Conventional hydrogels are able to mimic different characteristics
of the ECM of native tissues although they are typically associated
with a number of disadvantages such as their low strength and
poor mineralization upon implantation, which limits their
application for engineering load-bearing tissues such as bone
and cartilage.46,47 As mentioned before, over the past years,
different types of NPs have been extensively used as mechanical
reinforcers of hydrogels and bioinks.13,48,49 Inspired from the
nanomaterials found in biological tissues, a range of bioactive
inorganic NPs, including calcium phosphates (hydroxyapatite,
tricalcium phosphates) and nanosilicates (silica NPs, bioglass
NPs, and nanoclays), has been explored to develop bioinks with
adequate rheological characteristics to obtain 3D constructs
showing high printing fidelity and biocompatibility.50–52 None-
theless, the mentioned inorganic NPs own more functionalities
beyond simple mechanical reinforcement since most of them
consist of minerals that are present in human tissues and are
necessary for normal physiology (e.g., around 60 wt% of bone is
composed of hydroxyapatite).53 Moreover, these type of NPs has
shown good biocompatibility and favorable biological responses
in different cell types.54,55 For example, calcium and phosphate,
which can be released from calcium phosphates, stimulate the
deposition of the mineralized matrix by osteoblasts and prevent
bone loss.56 Similarly, silicon, another mineral component pre-
sent in nanosilicates, stimulates the osteogenic differentiation of
human stem cells and also promotes collagen type I synthesis.57
The release of these minerals from inorganic NPs can be
leveraged to enhance the bioactivity of bioinks and improve
cell adhesion, proliferation and influence differentiation of
diverse cell types into specific lineages (e.g. osteogenic).
Various nanocomposite bioinks based on calcium phosphate
nanoelements have been developed to enhance osteogenic differ-
entiation and to promote mineralization in tissue-engineered
3D-bioprinted constructs. For example, in a recent study, human
adipose-derived stem cells (hASCs) encapsulated in chitosan-
based bioinks incorporating 2%w/v nanohydroxyapatite particles
showed peak expression levels for early and late stages osteogenic
markers.58 It was concluded that cells within the nanocomposite
hydrogels had mineralized and differentiated into osteogenic
lineage after 21 days of culture. Likewise, micro-and nano-
hydroxyapatite incorporated within collagen, gelatin, and hyaluronic
acid-based bioinks promoted the mineralization of the 3D
bioprinted constructs.59–61
Nanosilicates are a different type of inorganic nanofillers
with anisotropic platelet-shapedmorphology (20–50 nm in diameter
and 1–2 nm thickness) showing a high degree of functionality and
applications in cosmetics and toothpaste as well as drug delivery
and TE.62,63 Among these, LAPONITEs XLG has been extensively
studied for biomedical applications due to its lower heavy metal
content.51 The use of silicate nanoplatelets was shown to
significantly enhance the osteogenic differentiation of human
mesenchymal stem cells (hMSCs) in typical 2D culture systems64,65
and encapsulated in GelMA hydrogels using growth factors free
medium.66 Moreover, these NPs show negatively charged faces
and positively charged edges, which allow reversible electrostatic
interactions with charged polymer backbones. Relying on this
characteristic, Gaharwar et al. used nanosilicates to reinforce
an ionic-covalent entanglement hydrogel composed of GelMA
and k-carrageenan, creating a dually reinforced hydrogel network.67
This nanoengineered ionic covalent entanglement (NICE) bioink
showed an excellent printability and allowed to print 3D constructs
with high aspect ratio and high printing fidelity while, at the same
time, showing high cell viability and proliferative capacity. More
notably, in a later work, the bioprinted constructs induced
endochondral differentiation of encapsulated hMSCs in the
absence of osteoinductive agents (Fig. 4).68,69 Besides, due to
their shape, these anisotropic NPs are able to align under shear
during 3D printing.67,68 Therefore, the incorporation of anisotropic
fillers can be leveraged for supporting not only the printing process
but also to promote cell alignment required to recreate anisotropic
tissues such as tendon, muscle, cartilage, and their interfaces.12,21
Other types of nanofillers have also been evaluated to provide
bioinks with enhanced mineralization functionality. For instance,
the addition of strontium–carbonate NPs has been demon-
strated as an efficient strategy to increase the printability and
the mineralization degree of GelMA-based hydrogels, thus
inducing the osteogenic differentiation of the MSCs encapsulated
within the nanocomposite 3D bioprinted constructs.70
Although inorganic NPs have been mostly used to develop
bioinks for bone regeneration approaches, their beneficial
effects in cells from softer tissues (e.g. cartilage and osteochondral
tissues) have widened the application of bioinks containing these
NPs.50,51 In addition, considering the capabilities of bioprinting to
place cells and materials in the 3D space, the recreation of
gradient tissue interfaces (tendon-to-bone, osteochondral tissues)
can largely benefit from these approaches. Moreover, as discussed
in previous sections, inorganic NPs have also been used as
therapeutic drug/growth factors delivery agents, which could
potentially lead to the development of single NPs showing
multiple functionalities.
2.3. Providing stimuli-responsive functionalities with smart
nanoparticles
The design of hydrogels with stimuli-responsive properties is an
essential challenge for their subsequent application in different
areas of the biomedical field. Actually, these hydrogels have been
shown to control the release in drug delivery formulations or to
mimic the native tissues in terms of physicochemical properties
and/or control over the behavior of the encapsulated cells for
TE purposes.71,72 The chemical modification of the hydrogels
precursor solutions to render them sensitive to light, acoustic, or
pH stimuli has been widely analyzed, being the incorporation of
nano-structured smart materials that provide hydrogels with
responsive properties another well-explored strategy.73,74 So far,
NPs with magnetic and electric properties have been the most
evaluated as potential nanofillers in the design of stimuli-
responsive nanocomposite hydrogels for biomedical applications.
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In this sense, the development of scaffolds with electric-
responsive properties is an essential challenge in fields such as
neural, muscle, or cardiac TE, where the transmission of nerve
impulses across the body and heart contractile properties present
electrical origins. Although the use of polymers with weak
conductive properties like polypyrrole or polyaniline has been
evaluated for these applications,75,76 the incorporation of electric
nanofillers based on carbon structures (e.g. carbon nanotubes
and graphite-based nanomaterials) or noble metals (e.g. gold and
silver NPs) has been a more widely analyzed strategy.77–80 On the
other hand, magnetic materials have been used to provide nano-
composite hydrogels with anisotropic structure and magneto-
mechanic stimulation properties through the application of
external magnetic fields.12 The intrinsic properties of magnetic
nanoparticles (MNPs) allow control over their distribution within
the 3D space of hydrogel networks by applying magnetic radiations,
opening the possibility to the design of anisotropic magnetically-
responsive constructs.12 MNPs with superparamagnetic behavior
are especially appealing for this purpose since in this regime, the
particles do not retain any magnetization energy after the
application of an external magnetic field, which precludes the
formation of aggregates and allows full control over their
magnetic guidance/distribution.81,82
The incorporation of nanofillers to render light-responsive
hydrogels has also been explored, being graphite–graphene
oxide structures among the most commonly utilized for this
fabrication strategy.83,84 Besides their aforementioned electrical
response, graphite-derived composites are also light-sensitive,
which allows their use as reinforcement materials to develop
hydrogels with adjustable properties through the application of
external light stimuli.85 The infrared light absorption properties
of graphite oxide nanostructures were used, for instance, to
endow faster photothermal excited responsivity of the prepared
nanocomposite hydrogels.84
Moreover, this kind of particles can also be used to provide
hydrogels with multiple functionalities beyond the ability to be
manipulated through the application of different external stimuli.
The intrinsic physicochemical properties of stimuli-responsive
Fig. 4 Bioinks with ceramic nanoparticles to induce mineralization: (a) development of NICE bioink composed of GelMA, kappa-carrageenan and
LAPONITEs XLG, loaded with MSCs. Scanning electron microscopy images showed a gradual decrease in the pore size of cell-laden 3D bioprinted
scaffolds due to deposition of ECM by cells. EDS analysis corroborated an increase in calcium and phosphates content after 60 days of culture due to
osteogenic differentiation of hMSCs, while histology stains demonstrated the osteochondral production of mineralized cartilage ECM (Safranin O stains
cartilage tissue in varying shades of red, while bone tissue is bluish-purple. Alcian Blue stains connective tissue light blue and cartilage dark blue)
(reproduced with permission from ref. 68 copyright 2020 American Chemical Society). (b) In a more recent work from the same group, NICE bioink was
used to reproduce various anatomical defects, such as jaw bone, eye socket or parietal bone, with high printing fidelity. Moreover, the osteoinductive
properties of 3D bioprinted NICE constructs can be augmented by depositing a pluripotent stem cell-derived ECM on them (bNICE: bioconditioned NICE
scaffolds). bNICE scaffolds increased the viability of the encapsulated hMSCs and the expression of osteogenic markers BMP-2 and OPN after 2 and 21
days of culture, respectively (reproduced with permission from ref. 69 copyright 2020 Wiley-VCH).




















































This journal is © The Royal Society of Chemistry 2021 J. Mater. Chem. B, 2021, 9, 5025–5038 |  5031
NPs and/or their manipulation/functionalization with different
substances have been exploited in this sense. For example,
nanocomposite hydrogels with incorporated MNPs have been
evaluated as potential tools for magnetic resonance imaging
(MRI).86 On the other hand, stimuli-responsive nanofillers were
also used as adsorbents of growth factors to then deliver them
within hydrogels following the strategies described in Section
2.1. For instance, Zhou et al. decorated graphene oxide flakes
with TGF-b3, which were then incorporated within collagen
hydrogels, allowing the chondrogenic differentiation of the
encapsulated hMSCs through the controlled delivery of trans-
forming growth factor.87
The combination of the design strategies to prepare nano-
composite hydrogels with stimuli-responsive properties and 3D
bioprinting technique has the potential to develop a new generation
of advanced scaffolds for TE applications. The modification of
bioinks with smart materials that can be stimulated through the
application of external stimuli adds a new dimension (time) to the
typical 3D bioprinting processes, which have been referred to as
‘‘4D bioprinting’’.88 The same manufacturing techniques and
procedures applied for 3D bioprinting are used when this new
‘‘dimension’’ is incorporated, being the difference in the controlled
and predefined functionalities that the smart materials add to the
designed composites.89 In this manner, the designed 3D bioprinted
constructs can be manipulated over time during/after their fabrica-
tion by applying different external stimuli, being possible to control
their mechanical response, architecture, shape, function, or other
physicochemical properties upon exposure to the aforementioned
stimuli. The external stimuli applied to induce changes in the
physical and/or chemical properties of the smart materials and,
consequently, in the constructs where they were incorporated can
have different nature, such as heat, light, acoustic waves, pH, or
electromagnetic fields.
However, the amount of works that report the incorporation
of cells in the (bio)inks and the development of 4Dbioprinted
nanocomposite scaffolds with stimuli-responsive properties is still
limited.90 For instance, Betsch et al.91 exploited the magnetic
response of iron oxide NPs incorporated within collagen-agarose
bioinks for cartilage TE purposes. A weak magnetic field of 2 mT
was applied during the printing process, observing that the
unidirectional motion of theMNPs induced by the external stimuli
forced the alignment of collagen fibers. Anisotropic composites
with random-to-aligned collagen fibers distribution were designed
with this strategy, combining aligned layers prepared under the
effect of the magnetic field with random layers, mimicking in this
way the complex architecture of native cartilage. The designed
scaffolds showed reinforced mechanical properties in comparison
with monolayer composites and increased the expression of
collagen type II of the loaded chondrocytes (Fig. 5a). In a different
work from our group, magnetically-responsive cellulose nanocrys-
tals have been incorporated as reinforcement materials in platelet
lysate-based bioinks.92 The designed bioinks allowed the bio-
fabrication of constructs with high resolution that mimic the
fibrillar structure of different native tissues, being also able to
support the bioprinting of stem cells with high viability immediately
after extrusion and over long-term cell culture. Although external
magnetic stimuli was not applied to the 3D bioprinted composites,
the ability to magnetically align cellulose nanocrystals within differ-
ent hydrogels has beenwidely analyzed in previous works.72,93 In this
way, the developed bioink is a promising candidate to create 3D
bioprinted anisotropic composites with magneto-mechanical stimu-
lation properties through the application of external magnetic fields.
A very interesting design of bioinks with electrically-responsive
nanofillers was explored in a recently reported work.94 Ti3C2M-
Xenes nanosheets, novel 2D transition metal carbides/nitrides
with outstanding properties in terms of electrical conductivity
and biodegradability, were incorporated within hyaluronic acid/
alginate cell-laden inks. The designed bioinks showed high print-
ability and displayed excellent rheological properties, which
allowed the fabrication of multilayered scaffolds with high
resolution and shape fidelity. Moreover, the incorporation of
the nanofillers provided the 3D bioprinted scaffolds with high
electrical conductivity, and encapsulated human embryonic
kidney 293 cells displayed high viability, suggesting that the
designed composites can be applied to engineer electrically
responsive tissues. In another relevant example, gold nanowires
were incorporated within collagen-based bioinks to provide the
printed scaffolds with electrical properties and generate topo-
graphical cues for the encapsulated cells.95 Although the shear
forces generated during the printing process induced a certain
orientation of the gold nanostructures, an external electric field
of 5 V and 1 Hz was applied to accelerate the alignment of the
nanofillers within the printed constructs. The designed anisotropic
composites induced high alignment degrees of the encapsulated
myoblasts and efficient myotube formation, constituting a new
prospective platform for the effective formation of muscle tissues
(Fig. 5b). Carbon nanotubes have also been evaluated as potential
electrically-responsive reinforcement materials for polymeric
bioinks. For example, Izadifar et al.96 incorporated these nano-
structures within alginate-collagen bioinks for cardiac TE appli-
cations, observing that the 3D bioprinted composites offered
significantly higher electrical conductivity and a compressive
modulus. Moreover, the designed hybrid cardiac constructs
promoted the proliferation, migration, and lumen-like organi-
zation of the encapsulated human coronary artery endothelial
cells, which confirms their great potential for myocardium
regeneration and vascularization.
Despite the above-discussed examples, the incorporation of
stimuli-responsive materials has a relevant impact on the physico-
chemical properties and printability of the polymeric solutions,
which still requires important hardware configuration evolutions
to fully explore all the design possibilities that this technology
promises, especially in the case of stimuli-assisted bioprinting.
Moreover, the potential cytotoxicity of the nanofillers and/or the
applied stimuli over the cells incorporated in the bioinks must
also be considered, which still limits the applicability of these 4D
bioprinting strategies.17
2.4. Bioinks with nanoparticles for real-time monitoring
The complexity of 3D bioprinting techniques has been signifi-
cantly increased in recent years trying tomeet the advances in the
field of TE. In this sense, the monitoring of different variables,




















































5032 |  J. Mater. Chem. B, 2021, 9, 5025–5038 This journal is © The Royal Society of Chemistry 2021
such as the oxygen gradient or the diffusion of nutrients, has
become crucial to ensure the development of real-size 3D bio-
printed tissues and organs.97 Optical analysis or the use of
chemical and physical sensors, among other techniques, have
already been explored for this purpose. However, the most recent
advancements in 3D cell culture require more sophisticated
methods for real-time monitoring based on minimally invasive
protocols that ensure negligible effects on cell culture maturation
processes.98,99 The biochemical indicators are the most effective
tools to allow real-time monitoring of the physiological status of
healthy and diseased tissues. The progress in this direction can
not only ensure precise diagnoses through the development of
accurate disease models, but it can also pave the way for effective
treatment strategies.98,100 In this way, as mentioned in previous
sections, the use of NPs with tunable features has been positively
evaluated to achieve precise control over the functional and
behavioral properties of hydrogel-based systems applied in TE
and regenerative medicine.101 For instance, Li et al.102 developed a
hybrid nanocomposite that provided multifunctional properties
not only to enhance osteoblastic differentiation and reduce
inflammation but also to offer a non-invasive technique to monitor
material degradation in vivo through simple fluorescence changes.
Besides optical and biochemical techniques, the integration
of electrochemical sensing103 in the cell culture of 3D scaffolds
to monitor real-time cell environment is another promising
direction to develop biomimetic platforms with the capacity to
closely observe cell processes.104–106 Following this approach,
Hu et al.107 combined the biomimetic properties of 3-amino-
phenylboronic acid with the mechanical and electrochemical
characteristics of a graphene network, thus developing a real-
time electrochemical monitoring platform for long-term cell
culture. In this way, the design of biomaterials with high
Fig. 5 Bioinks with stimuli-responsive nanoparticles: (a) 3D bioprinting stage including an adaptor for a magnet that allow the application of an external
magnetic field during the process (magnetically-assisted bioprinting). This strategy allowed the preparation of bi-layer constructs with random-to-
aligned collagen fibers organization similar to that observed in native cartilage tissues. In the aligned layer, collagen fibers were organized exploiting the
unidirectional traveling motion of the MNPs incorporated in the bioink induced by the applied magnetic field. The chondrocytes embedded in the 3D
bioprinted samples produced a matrix with high expressions of ACAN and COL II chondrogenic markers (reproduced with permission from ref. 91
copyright 2018 Wiley-VCH). (b) Schematic illustration of the 3D bioprinting process of collagen-based bioinks modified with gold nanorods for muscle
TE: the shear forces generated during the printing induced a relatively high orientation of the nanofillers, which was improved by applying an external
electric field to the 3D bioprinted composites. The nanorods acted as cell anchorage sites, enhancing the viability and proliferation of the encapsulated
myoblasts. Moreover, the created topographical cues induced significant elongated morphologies and structural alignment of the cells, as well as high
expressions of myogenic-related markers. The anisotropic bioprinted composites were also evaluated in vivo through implantations in the temporalis
muscle flap, observing their completely transformation into matured myofibers in which nuclei were located on the peripheral region, the final position of
the nucleus in muscle maturation process (reproduced with permission from ref. 95 copyright 2019 American Chemical Society).
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electroconductivity is established as a promising tool for the
electrochemical sensing of cells with high sensitivity and temporal-
spatial resolution.104,107
The modification of bioinks using different NPs has already
been explored and proven to be a highly effective strategy to
fabricate complex 3D bioprinted constructs, as discussed in
previous sections. Currently, in the field of TE, the 3D bioprinting
technique is primarily focused on the fabrication of miniature
functional equivalents of tissue and/or organs. However, this
reduced-scale fabrication approach hinders the monitoring of
the 3D constructs, characterized by the presence of multiple cell
types and materials, which increase the complexity/variability in
the microenvironment created in the confined space.108,109 NPs
have been proposed as potential tools to monitor the cell
maturation within the low-scale 3D bioprinted constructs due
to their easy preparation and functionalization, which allow to
provide them with the required functionality.110–112
Following this approach, bioactive glass NPs were evaluated
for the real-time monitoring of 3D printed constructs for bone
TEpurposes.113 The assembly of poly(citrate-siloxane) on the
surface of the NPs increased the toughness of the printed
constructs, improved the osteogenic activity, and provided
them with photoluminescence, allowing real-time bioimaging
monitoring. Similarly, Gou et al.114 developed a nanocomposite
in which polydiacetylene NPs were dispersed in polymeric
matrices for detoxification purposes. The incorporated NPs
were able not only to sense the toxins but also to attract and
capture them. This work highlights how 3D printed biomimetic
nanocomposites can be explored for the generation of detoxification
platforms. Although both aforementioned works do not incorporate
cells in the 3D printing process, they provide a valuable proof-of-
concept showing the potential of nanocomposite hydrogels to allow
the real-time monitoring of the biofabricated constructs.
So far, the number of works that report the combination of
3D bioprinting strategies with the incorporation of NPs for real-
time monitoring purposes is still reduced. For example, NPs
functionalized with oxygen-sensitive indicators were developed
and incorporated within alginate-methylcellulose-based bioinks
in order to monitor the cells encapsulated within the 3D
bioprinted constructs.115 Using this system, the oxygen levels
and the metabolic activity of different cell types within intact 3D
structures were imaged using optical sensors (Fig. 6). This work
opens new opportunities to combine the established methods
to prepare nanocomposite hydrogels with the development of
Fig. 6 Bioinks with nanoparticles for real time monitoring: polymeric NPs were modified with an oxygen-sensitive red-emission indicator (platinum(II)
meso(2,3,4,5,6-pentafluoro) phenyl porphyrin; PtTFPP) and incorporated within alginate/methylcellulose bioinks. The designed 3D printed scaffolds
containing only O2-sensitive NPs (without cells) showed a quasi-exponential decrease in the ratio of O2-dependent luminescence (red) over the constant
reference emission (green), with increasing O2 levels ranging from anoxia to full atmospheric saturation (21% O2). The spatiotemporal dynamics of O2
concentration in multilayered 3D-bioprinted constructs with sensor NPs and green microalgae or human mesenchymal stem cells were also evaluated.
The local O2 level was higher in the compartments containing MSCs than in those containing microalgae, indicating mixotrophy of the algal cells with a
respiratory activity higher than that of the mammalian cells. The extracted profiles showed the formation of distinct O2 concentration gradients that were
affected by the activity of the different cell types and diffusive exchange between the compartments. After 30 min in dark, the O2 concentration in the
layer with microalgae reached anoxia about 1 mm from intersections to layer with MSCs (that only depleted O2 to about 14%). In light, the photosynthetic
O2 production alleviated the strong O2 depletion in the compartments with microalgae, leading to less O2 concentration differences respect to MSCs
layers (reproduced with permission from ref. 115 copyright 2018 Wiley-VCH).
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non-invasive techniques to map cell metabolism and to analyze
their microenvironment in real-time after 3D bioprinting.
Despite the few bioprinted constructs that incorporate NPs
for monitoring, the developments carried out in this area
provide a future prospect to use NPs as biosensing entities in the
formulation novel multifunctional bioinks. These new nanocompo-
site bioinks can be applied to provide the 3D bioprinted tissue/
organswith the capability to accuratelymonitor cells behavior during
long-term culture studies without using invasive techniques.116
3. Concluding remarks and future
outlook
In the last years, 3D bioprinting has emerged as a novel technique
with an impressive potential in the biomedical field, enabling the
construction of customized complex tissue surrogates with
hitherto unknown fidelity and precision. The capability to create
spatial patterns with multiple materials and cell types are unique
advantages of 3D bioprinting over other fabrication technologies
in order to mimic the complexity of human tissues microenviron-
ments. Moreover, the potential of this technique to translate the
experiments from micro- to macroscale can help to close the gap
between on-bench success to industrial production and clinical
translation.
The design of bioinks with the suitable characteristics is an
essential factor to provide the final 3D bioprinted constructs
with the desired properties for their specific applications. The
use of hydrogels is the most common approach to prepare
these bioinks, but single-hydrogel based formulations hinder
the design of constructs meeting the required properties/
functionalities for the regeneration of certain tissues and for
their application in specific interface areas of the biomedical
field. In this sense, the incorporation of NPs has emerged as an
intriguing choice to develop advanced nanocomposite bioinks
with (multi)functional properties.117
The different tissues of the human body are characterized by
unique microenvironments, making of multiresponsive and
multifunctional nanocomposite hydrogel systems ideal candidates
to guide a wide range of tissue regeneration processes. Following
this concept, the modification of bioink hydrogels with functional
nanomaterials has been a logical step to design 3D bioprinted
constructs with the desired characteristics for their specific
regenerative application. A wide range of NPs has been com-
bined with different biological factors and incorporated within
hydrogels to recreate in the bioprinted constructs the complex
biological signaling processes that occur in native tissues and
organs. Moreover, inorganic NPs, such as calcium phosphates
or nanosilicates, have demonstrated their potential to induce
the mineralization effects required for the bone or cartilage TE,
among other applications. Externally addressable NPs that respond
to electromagnetic fields, acoustic waves, or light irradiations have
been applied to develop hydrogels with the potential to deliver
different stimuli to cells and improved the regeneration of
electro-responsive organs/tissues or mechanosensitive tissues.
Remarkably, NPs have also been leveraged to develop bioink
systems allowing the real-time monitoring of different para-
meters of cell activity during the in vitro maturation of bio-
printed constructs (Table 1).
However, the number of works that explored this bioprinting
concept is still limited, perhaps due to some unsolved problems
related to the addition of nanomaterials to bioink hydrogels.
First, the incorporation of functional NPs is an excellent
approach to provide the final constructs with desired functionality
Table 1 Main characteristics of different relevant (bio)inks incorporating functional micro- and nanofillers
Main functionality Filler nature Filler dimensions (Bio)ink Cells Application Ref.
Biological factors
release
Gelatin@VEGF particles 75–125 mm Alginate/matrigel hEPCs TE 43
BSA-TGF-b1@PLGA NPs 60–120 nm GelMA/PEGDA Bone marrow hMSCs Cartilage TE 44
Hydroxyapatite@pDNA NPs 200 nm Alginate/methylcellulose Bone marrow-derived
MSCs
TE 45
Mineralization Hydroxyapatite nanorods 183  34 nm Alginate hASCs Bone TE 58
Chitosan
Hydroxyapatite nanorods 20  40–60 nm Collagen — Bone TE 59
Hydroxyapatite particles 12 mm GelMA hASCs Bone TE 60
MeHA
Hydroxyapatite NPs o100 nm Collagen — Bone TE 136
Nanosilicates
(LAPONITEs XLG)




Magnetite particles 20–50 mm Alginate/methylcellulose hMSCs Muscoskeletal TE 90
Iron oxide NPs 10–12 nm Collagen/agarose Chondrocytes Cartilage TE 91
Cellulose nanorods 206  12 nm Platelet lysate hASCs TE 92
Iron oxide NPs 10 nm Alginate/methylcellulose — — 132
Electric
responsive
Ti3C2MXene nanosheets 4 nm  4 mm Alginate/HA HEK-293 Neural TE 94
Gold nanowires — Collagen C2C12 myoblasts Muscle TE 95
Carbon nanotubes 30 nm  5–20 mm Alginate HCAECs Cardiac TE 96
Methacrylated collagen
Graphene nanoplatelets 8 nm  25 mm Resin — Biomedical 135
Real-time
monitoring




PSMA: poly(styrene maleic anhydride); PtTFPP: platinum(II) meso(2,3,4,5,6-pentafluoro)phenyl porphyrin; BSA: bovine serum albumin; PLGA:
poly(lactic-co-glycolic acid); pDNA: plasmid DNA; (Me)HA: (methacrylated)hyaluronic acid.
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and tunability, but it also has a considerable impact over the
processability of the bioinks.118 On the other hand, different
types of NPs are characterized by non-negligible cytotoxicity
degrees,119,120 which limits the amount of particles that can be
incorporated in the bioink, making it difficult in cases to
provide the final constructs with the desired functionalities.
Moreover, the mechanical properties of the majority of 3D
bioprinted nanocomposite constructs are still not satisfactory for
implementation in certain TE strategies, especially to engineer
high-load bearing tissues. The design of 3D bioprinted nano-
composite scaffolding materials displaying the desired functional
properties combined with the required mechanical/biological
performance is still a challenge. The combination of functional
bioinks with structured scaffolds that provide the final hybrid
constructs with the desired load-bearing capacity is an interesting
and still under explored strategy to address this limitation. In this
point, convergence of extrusion or microfluidic-based bioprinting
using the described multifunctional bioinks with melt electro-
writing or electrospinning technologies emerge as promising
approaches to design fibrillar scaffolds with isotropic/anisotro-
pic architectures and controlled load-bearing capacity matching
the need of different tissues.121,122 Despite the already identi-
fied limitations, the remarkable engineering design space that
the next generation of 3D bioprinted functional nanocompo-
sites offers for improving the regenerative outcome of a wide
range of TE strategies is not easily assessable to alternative
technologies, and therefore we expect to see major develop-
ments in this field in coming years. Although it is difficult to
predict the progress directions of the field, we anticipate that
nanocomposite bioinks incorporating NPs combining multiple
functionalities will likely be developed. For example, electrically-
responsive NPs decorated with growth factors have already been
designed and incorporated within polymeric hydrogels to provide
them with stimuli-responsive properties and induce the differentia-
tion of the encapsulated cells.87 Moreover, particles that combine
electric and magnetic responses have also been synthesized by
growing electric shells surrounding MNPs.123 These hybrid nanos-
tructures could be particularly useful to prepare 3D bioprinted
scaffolds to engineer tissues with anisotropic structure and respon-
sive to electrical stimuli, such as cardiac tissues or nerves. Hybrid
ceramic-electric124 and ceramic-magnetic125 NPs have also been
prepared, being an interesting approach to provide 3D bioprinted
scaffolds withmultifunctional properties in terms ofmineralization
induction and electromagnetic responsive properties. The incor-
poration of these nanostructures in the bioinks could be interesting
to engineer 3D bioprinted scaffolds for anisotropic tissues with
high anisotropic degrees such as cartilage. Moreover, NPs can
also be incorporated in the bioinks to provide 3D bioprinted
nanocomposites with other functionalities than the main ones
that we have discussed in previous sections. For instance, it has
been established that silver126 and magnesium oxide127 NPs show
potent antibacterial properties and wound healing capabilities.
Similarly, cerium oxide NPs (nanoceria) possess catalytic activity
for diverse enzymes and electrochemical characteristics that allow
fast electron transfer.128 These characteristics have attracted
considerable attention in the last few years for the development
of highly-sensitive biosensors.128 Also, nanoceria has been evaluated
as an efficient tool to design nanoplatforms with impressive anti-
oxidant and antimicrobial activities targeting the treatment of dis-
eases characterized by high levels of reactive oxygen species (ROS),
among others.129,130 For instance, it was demonstrated that poly-
meric electrospun nanofibers decorated with nanoceria can alleviate
ROS production in neonatal primary cardiomyocytes, thus actuating
as a negative regulator of agonist-induced cardiac hypertrophy.131 In
this way, the incorporation of nanoceria in the bioinks might open
multiple possibilities for the fabrication of 3D bioprinted constructs
with multifunctional properties for biomedical purposes.
Beyond the added functionality, nanocomposite bioinks can
be leveraged to add a new level of biofabrication control and
increase the nano- to macroscale precision of nanocomposite
constructs. In this sense, a very interesting underexplored approach
is the use of stimuli-assisted bioprinting, which consists of the
application of external stimuli to the bioinks during the printing
process. This strategy has the potential to significantly increase the
control over the design of nanocomposite scaffoldingmaterials with
different types of stimuli-responsive NPs. Typically, the responsive
properties of the nanofillers incorporated in the bioinks are
exploited by applying the specific external stimulus before or after
the printing processes.90,132 However, in the last few years different
works explored the application of the stimuli during the manufac-
turing step.133 This approach is especially appealing in the case of
electromagnetic inks, in which the application of external electro-
magnetic fields during the printing processes (electrically- and
magnetically-assisted printing) allows a great control over the spatial
distribution of smart nanomaterials and, therefore, over the
architecture and anisotropy degree of the printed constructs.
For instance, Kokkinis et al.134 incorporated a rotary neodymium
magnet close to the printing platform of a commercial 3D printer
that generates an alternating magnetic field of 40 mT and 8.3 Hz.
The drag magnetic forces created by the magnetic setup induced
the biaxial alignment of the magnetic materials incorporated
in the inks within the plane of the rotating field, designing
constructs with well-controlled anisotropy. In a representative
recent work in the field of electrically-assisted printing, graphene
nanoplatelets were incorporated in polymeric inks and printed
under the application of an external electric field of 433 V cm1.
The external stimuli applied during the printing process aligned
the electrically-responsive nanofillers, creating printed constructs
with enhanced toughness and highly-anisotropic electrical properties
with potential application in the field of TE.135
All these possible bioprinting approaches are just a few
examples identified to demonstrate that the potential of nano-
composite bioinks in biomedical applications is wide but still
far from being fully exploited. We expect that this perspective
review will contribute to foster the discussion on the topic and
foresee major developments in bioprinting with nanocomposite
bioinks to improve the regenerative outcomes of TE products.
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